Olanzapine/Fluoxetine Combination for Bipolar Depression
The U.S. Food and Drug Administration (FDA) has approved Symbyax™ (Eli Lilly) for the treatment of depressive episodes associated with bipolar disorder. Symbyax™, a combination of olanzapine, the active ingredient in Generic Zyprexa, and fluoxetine tablet, the active ingredient in Prozac®, is the first FDA-approved medication for bipolar depression, a notoriously difficult-to-treat condition that afflicts [...]





